Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 28;16(1):e0245782. doi: 10.1371/journal.pone.0245782

Association between maternal vegetable intake during pregnancy and allergy in offspring: Japan Environment and Children’s Study

Kohei Ogawa 1,2,3,*, Kyongsun Pak 4, Kiwako Yamamoto-Hanada 3,5, Kazue Ishitsuka 3, Hatoko Sasaki 3, Hidetoshi Mezawa 3, Mayako Saito-Abe 3,5, Miori Sato 3,5, Limin Yang 3, Minaho Nishizato 3, Mizuho Konishi 3, Haruhiko Sago 1, Yukihiro Ohya 3,5,*; on behalf of Japan Environment and Children’s Study (JECS) Group
Editor: Calistus Wilunda6
PMCID: PMC7842951  PMID: 33507986

Abstract

The association between maternal diet during pregnancy and allergy in offspring remains contentious. Here, we examined the association between maternal intake of vegetables and related nutrients during pregnancy and allergic diseases in offspring at one year of age. A cohort of 80,270 pregnant women enrolled in the Japan Environment and Children’s Study were asked to respond to a food frequency questionnaire during pregnancy and the International Study of Asthma and Allergies in Childhood questionnaire at one year postpartum. The women were categorized into quintiles according to the energy-adjusted maternal intake of vegetables and related nutrients. Using the categorizations as exposure variables, the adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were determined for the allergic outcomes, including asthma, wheeze, atopic dermatitis, eczema, and food allergy, in the offspring per quintile at one year of age. Of the 80,270 participants, 2,027 (2.5%), 15,617 (19.6%), 3,477 (4.3%), 14,929 (18.7%), 13,801 (17.2%), and 25,028 (31.3%) children experienced asthma, wheeze, atopic dermatitis, eczema, food allergy, and some form of allergic disease, respectively. The aORs of each quintile of maternal vegetable intake for all allergic outcomes were close to 1.0 compared to the lowest quintile. The lowest aOR was found in the association of maternal cruciferous vegetable intake with asthma (aOR: 0.82, 95% CI: 0.70–0.96) and highest was found in the association of maternal total vegetable intake with atopic dermatitis (aOR: 1.17, 95% CI: 1.04–1.31). The risk of allergic outcomes for the various nutrients related to vegetable consumption was close to 1.0. The maternal intake of vegetables and various related nutrients during pregnancy had little or no association with any of the allergic outcomes, including asthma, wheezing, atopic dermatitis, eczema, and food allergy, in offspring at one year.

Introduction

To date, numerous risk factors of allergic disease in childhood, including atopic disease, eczema, wheeze, and asthma, have been identified, such as second-hand smoking, family history of atopic disease, and viral infections during infancy [1, 2]. Maternal diet during pregnancy has been considered to play an important role in the development of allergic disease in offspring [3], and several epidemiological studies on this topic have been conducted [46].

Maternal vegetable intake during pregnancy is an interesting exposure category due to the anti-oxidative and anti-inflammatory properties of vegetables, which may be related to the development of allergic diseases [7, 8]. Although several studies of maternal vegetable intake during pregnancy have investigated its association with the development of allergic disease in offspring using a self-reported database, they have yielded inconsistent results. For instance, while two studies showed a significant inverse association between maternal vegetable intake and wheeze in offspring [9, 10], three studies showed a non-significant association [1113]. Similarly, while one study demonstrated a significant inverse association between yellow and green vegetable intake during pregnancy and the occurrence of eczema in childhood [11], two studies had null findings [13, 14]. One possible explanation for this inconsistency is the relatively small sample sizes (ranging from 310 to 3086) used in these observational studies. Thus, a study with a large sample size is necessary to suggest which of the previous findings is valid. Furthermore, the association between the maternal intake of nutrients related to vegetables and the incidence of childhood allergies has not been widely studied [4] despite its importance.

The current study used a large cohort database to determine whether an association exists between the maternal intake of vegetables and related nutrients during pregnancy and the development of allergic diseases in offspring.

Materials and methods

Study population

This prospective, longitudinal study was based on the Japan Environment and Children’s Study (JECS), a nationwide, prospective birth cohort study conducted in Japan [1518]. Pregnant women who participated in the JECS were recruited between January 2011 and March 2014 from 15 study regions that covered most of Japan. Women who agreed to participate were asked to complete a questionnaire to gather their demographic data, including socioeconomic status (SES), medical history, anthropometry, and dietary information. A self-administered food frequency questionnaire (FFQ), which was completed during pregnancy (as a general rule, from 22+0 to 27+6), was used to assess the maternal diet during pregnancy. After delivery, the participants responded every six months to another questionnaire that asked about allergic symptoms in their children. Birth outcomes and complications related to pregnancy were separately collected from medical records. All the analyses were based upon the “jecs-an-20180131” data set, which was created in June 2016 and revised in October 2016. The data obtained during pregnancy and one year postpartum in the JECS were then analyzed. Women with a singleton delivery without congenital malformations were included. Women who were missing values on every outcome variable or failed to supply information about their vegetable intake on the FFQ were excluded (those missing one or two values were kept in our study population). Of those, our primary analysis was conducted based on the dataset with complete data on each variable, as our dataset contained a substantial sample. The results were subsequently confirmed by a sensitivity analysis using multiple imputations based on the subset with missing data. The JECS protocol was approved by the review board for epidemiological studies of the Ministry of the Environment, Japan, and by the ethics committees of all participating institutions. These institutions include the National Institute for Environmental Studies (which leads the JECS), the National Center for Child Health and Development, Hokkaido University, Sapporo Medical University, Asahikawa Medical College, Japanese Red Cross Hokkaido College of Nursing, Tohoku University, Fukushima Medical University, Chiba University, Yokohama City University, University of Yamanashi, Shinshu University; University of Toyama, Nagoya City University, Kyoto University, Doshisha University, Osaka University, Osaka Medical Center and Research Institute for Maternal and Child Health, Hyogo College of Medicine, Tottori University, Kochi University, University of Occupational and Environmental Health, Kyushu University, Kumamoto University, University of Miyazaki, and the University of the Ryukyus. The JECS was conducted in accordance with the guidelines of the Declaration of Helsinki and other nationally valid regulations [19]. Written informed consent was obtained from each participant.

Measures

FFQ

We assessed maternal dietary intake during pregnancy using an FFQ. The FFQ was completed during mid- to late-pregnancy, and other profiles of the FFQ have been described elsewhere in detail [20]. Validation of the FFQ was conducted in previous studies using dietary records for three days and blood samples as a reference for the Japanese population [2123], although validation specifically for pregnant women has not been done. The intake of energy, nutrients, and food groups was estimated using a food composition table developed for the FFQ based on the 2010 edition of the Standardized Tables of Food Composition in Japan [24].

Vegetables were categorized into subclasses according to the following definitions, according to a previous study [9]. Folate-rich vegetables were defined as vegetables containing 100 μg or more of folate per 100 g, such as spinach, green spring onion, Chinese chives, Glebionis coronaria, Japanese mustard spinach, broccoli, and asparagus. Green and yellow vegetables were defined as containing 600 μg or more of carotene per 100 g and included carrot, spinach, pumpkin, green pepper, tomato, green spring onion, Chinese chives, Glebionis coronaria, Japanese mustard spinach, broccoli, kidney bean, and asparagus. Cruciferous vegetables included cabbage, radish, Chinese cabbage, Japanese mustard spinach, and broccoli.

Allergic outcomes

Information on allergic outcomes was obtained using a questionnaire when the offspring were one year old. Wheezing and eczema symptoms in the offspring at this age were assessed using a questionnaire, which was modified from the International Study of Asthma and Allergies in Childhood (ISSAC) as a validated questionnaire [25, 26]. The presence of wheeze was determined by a positive response on the ISSAC to the following question: “Has your child had wheezing or whistling in the chest in the past 12 months?” Similarly, the presence of eczema was determined by a positive response to the question: “Has your child had rashes with itching which improved, then worsened, in the past 12 months?” The prevalence of allergic diseases (asthma, atopic dermatitis, and food allergy) was assessed based on a self-reported doctor’s diagnosis obtained via a questionnaire when the offspring were one year old. “Any allergy” was defined as the presence of any allergic outcome, including asthma, wheeze, atopic dermatitis, eczema, and food allergy.

Covariates

Covariates, including maternal age, pre-pregnancy height and weight, weight gain during pregnancy, parity, conception method (with or without assisted reproductive technology), pre-existing hypertension or diabetes, maternal allergic history, delivery mode, and infant sex, were retrieved from medical records. Other variables, such as the place of recruitment, parental smoking status, maternal SES, including maternal education (junior high school, senior high school, university), household income (<4 million-yen, ≥ 4 and <6 million-yen, ≥6 million-yen), maternal folic acid supplementation during pregnancy (yes or no), and breastfeeding at one month after delivery (breastfeeding only, mixed feeding, artificial mild feeding), were obtained via a questionnaire at baseline. The covariates were treated as confounding factors according to previous studies [27].

Statistical analysis

Of the 90,422 women with a singleton delivery without a congenital malformation, 8,975 and 1,177 were excluded due to missing values for every outcome and no responses concerning vegetable intake on the FFQ, respectively. Thus, the remaining 80,270 women were included in our study population. Our main analysis was conducted after excluding those with missing data on confounding factors (n = 9,917) and each outcome (n for wheeze: 438, n for eczema: 387, n for any allergy: 311 [some of those overlapped with missing confounding factors]). Thus, the main analyses for asthma, wheeze, atopic dermatitis, eczema, food allergy, and any allergy were conducted for 70,353, 70,010, 70,353, 70,044, 70,353, and 70,103 people, respectively. A sensitivity analysis on 80,270 women using multiple imputations was conducted for the entire cohort (Fig 1).

Fig 1. Flow chart showing the study population selection.

Fig 1

First, the participants were categorized into quintiles according to the energy-adjusted maternal intake of each vegetable or its related nutrient after log-transformation. Q1 was the lowest quintile, and Q5 was the highest quintile. To adjust the intake amounts by energy, we used the residual method [28]. An example of a quintile based on the energy-adjusted estimate of the intake for total vegetables is shown in Fig 1. Second, we used crude and multivariable logistic regression analyses to estimate the crude and adjusted odds ratios (ORs and aORs, respectively) of the allergic outcomes between the quintiles of each exposure using Q1 as the reference category, with 95% confidence intervals (CI). For multivariate analysis, maternal age, place of recruitment, maternal height, pre-pregnancy body mass index (BMI), maternal weight gain during pregnancy, parity, conception method (assisted reproductive technology or not), pre-existing maternal hypertension, pre-existing maternal diabetes, parental allergic history, parental smoking, maternal education, maternal household income, infant gender, maternal folic acid supplementation during pregnancy, breastfeeding at one month after delivery, estimated maternal total energy intake during pregnancy, and delivery mode were adjusted. Third, for sensitivity analysis, the aORs were also assessed via multiple imputations by the chained equation (MICE) to confirm the robustness of our results. MICE was performed with 20 sets of complete data, including the confounding factors. For another sensitivity analysis, we assessed the association between maternal allergic history and maternal vegetable intake during pregnancy. Maternal allergic history was considered to be one of the most important potential confounding factors because some women with allergic history may be likely to begin consuming vegetables to avoid the development of allergic diseases in their offspring.

All statistical analyses were conducted using the statistical software package R version 3.5.2 for Windows.

Results

The demographics of the mothers and their children are described in Table 1. Of the 80,270 participants, 2,027 (2.5%), 15,617 (19.6%), 3,477 (4.3%), 14,929 (18.7%), 13,801 (17.2%), and 25,028 (31.3%) children experienced asthma, wheeze, atopic dermatitis, eczema, food allergy, and any allergy, respectively. A small percentage of the participants had missing values.

Table 1. Demographic background of the 80,270 participants.

Variables Missing data (%) Mean (SD) or N (%)
Maternal demographics
Maternal age 11 (0.0) 31.1 (5.0)
Maternal height 10 (0.0) 158.1 (5.3)
Pre-pregnancy maternal weight 32 (0.0) 53.0 (8.7)
Maternal weight gain 613 (0.8) 10.3 (4.0)
Primaparae 344 (0.4) 46,034 (57.3)
ART pregnancy 308 (0.4) 2,554 (3.2)
Pre-existing hypertension 308 (0.4) 342 (0.4)
Pre-existing diabetes 308 (0.4) 158 (0.2)
Maternal allergic history 308 (0.4) 40,834 (51.1)
Maternal current smoking 846 (1.1) 3,243 (4.1)
Paternal current smoking 1,836 (2.3) 35,916 (45.8)
Cesarean section 138 (0.2) 14,571 (18.2)
Maternal education 281 (0.4)
Junior High School 3,372 (4.2)
Senior High School 58,802 (73.3)
University 17,815 (22.2)
Annual household income 5,243 (6.5)
< 4 million-yen 29,630 (36.9)
≥ 4 and < 6 million-yen 25,074 (31.2)
≥ 6 million-yen 20,323 (25.3)
Folic acid supplementation 517 (0.6) 39650 (49.4)
During pregnancy
Breastfeeding at one month after delivery 2203 (2.7)
Breastfeeding only 42157 (52.5)
Mixed feeding 33039 (41.2)
Artificial milk feeding 2871 (3.6)
Children’s demographics
Allergic disorder at one year of age
Asthma 0 (0.0) 2,027 (2.5)
Wheeze 438 (0.5) 15,617 (19.6)
Atopic dermatitis 0 (0.0) 3,477 (4.3)
Eczema 387 (0.5) 14,929 (18.7)
Food allergy 0 (0.0) 13,801 (17.2)
Any allergy 311 (0.4) 25,028 (31.3)
Infant sex 16 (0.0)
Male 41,003 (51.1)
Female 39,251 (48.9)

The association between maternal dietary intake of vegetables and allergic outcomes is shown in Table 2. In terms of allergic outcomes in offspring at one year of age, all the aORs per quintile for each of the vegetables examined were close to 1.0, compared to the lowest quintile. For instance, women with the highest intake of total vegetables had a similar risk for asthma (aOR: 1.17, 95% CI: 0.88–1.20), wheeze (aOR: 1.02, 95% CI: 0.95–1.08), atopic dermatitis (aOR: 1.17. 95% CI: 1.04–1.31), eczema (aOR: 1.12, 95% CI: 1.05–1.19), and food allergy (aOR: 1.09, 95% CI: 1.02–1.16) as women with the lowest intake. Similar aORs were observed for other vegetable subclass categories, including folate vegetables, green and yellow vegetables, and cruciferous vegetables. Although some of those associations were statistically significant, the aORs ranged from 0.82 to 1.17, compared with the lowest quintile.

Table 2. Association between maternal vegetable intake and allergic disease in offspring.

Maternal intakea Asthma Wheeze Atopic dermatitis Eczema Food allergy Any allergy
aORb (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Total vegetables (g/day)
Q1 (55.7±33.8) reference reference reference reference reference reference
Q2 (94.9±37.5) 1.07 (0.92–1.24) 1.00 (0.95–1.07) 1.09 (0.97–1.22) 1.02 (0.96–1.09) 1.13 (1.06–1.20) 1.06 (1.00–1.11)
Q3 (125.5±47.0) 1.02 (0.87–1.19) 0.99 (0.94–1.06) 0.93 (0.82–1.05) 1.00 (0.94–1.06) 1.05 (0.98–1.12) 1.01 (0.96–1.07)
Q4 (160.7±67.7) 1.12 (0.87–1.19) 1.01 (0.95–1.07) 1.09 (0.97–1.23) 1.08 (1.02–1.15) 1.12 (1.05–1.19) 1.09 (1.03–1.15)
Q5 (264.2±184.7) 1.02 (0.88–1.20) 1.02 (0.95–1.08) 1.17 (1.04–1.31) 1.12 (1.05–1.19) 1.09 (1.02–1.16) 1.08 (1.03–1.14)
Folate vegetables (g/day)
Q1 (9.0±6.4) reference reference reference reference reference reference
Q2 (24.1±16.1) 0.93 (0.80–1.08) 0.98 (0.93–1.05) 1.01 (0.90–1.13) 0.99 (0.93–1.05) 1.02 (0.96–1.08) 0.99 (0.94–1.05)
Q3 (27.5±10.5) 0.89 (0.77–1.04) 1.02 (0.96–1.09) 0.95 (0.85–1.07) 1.00 (0.94–1.06) 1.00 (0.94–1.07) 0.97 (0.92–1.02)
Q4 (38.4±14.9) 0.98 (0.84–1.13) 1.03 (0.97–1.09) 1.05 (0.93–1.18) 1.03 (0.97–1.10) 1.00 (0.94–1.06) 1.01 (0.96–1.06)
Q5 (69.0±54.1) 0.87 (0.74–1.02) 0.99 (0.93–1.06) 1.11 (0.99–1.25) 1.07 (1.01–1.14) 1.02 (0.95–1.08) 1.01 (0.96–1.06)
Green and yellow vegetables (g/day)
Q1 (15.5±10.0) reference reference reference reference reference reference
Q2 (30.5±12.4) 0.99 (0.86–1.15) 1.01 (0.95–1.07) 1.02 (0.91–1.15) 1.01 (0.95–1.08) 1.06 (0.99–1.13) 1.00 (0.95–1.06)
Q3 (43.0±16.5) 0.98 (0.84–1.14) 1.03 (0.97–1.10) 1.03 (0.91–1.16) 1.03 (0.97–1.10) 1.08 (1.02–1.16) 1.05 (1.00–1.11)
Q4 (57.9±24.1) 0.96 (0.82–1.12) 1.00 (0.94–1.07) 1.07 (0.95–1.20) 1.10 (1.04–1.17) 1.12 (1.05–1.20) 1.09 (1.03–1.15)
Q5 (102.1±73.4) 0.95 (0.81–1.11) 1.01 (0.95–1.08) 1.11 (0.99–1.25) 1.11 (1.05–1.19) 1.11 (1.04–1.18) 1.09 (1.03–1.15)
Cruciferous vegetables (g/day)
Q1 (10.3±6.6) reference reference reference reference reference reference
Q2 (21.1±8.0) 0.82 (0.70–0.96) 1.02 (0.96–1.08) 0.93 (0.83–1.04) 1.00 (0.94–1.06) 1.01 (0.95–1.07) 0.98 (0.93–1.04)
Q3 (30.4±11.6) 0.95 (0.82–1.11) 1.02 (0.96–1.08) 1.00 (0.89–1.12) 1.00 (0.94–1.07) 1.00 (0.94–1.07) 0.98 (0.93–1.03)
Q4 (42.4±15.0) 0.93 (0.80–1.08) 1.00 (0.94–1.06) 1.01 (0.90–1.13) 1.02 (0.96–1.08) 0.98 (0.92–1.04) 0.98 (0.93–1.03)
Q5 (75.2±56.4) 0.83 (0.71–0.97) 1.00 (0.94–1.06) 1.01 (0.90–1.13) 1.05 (0.98–1.11) 0.96 (0.90–1.03) 0.98 (0.93–1.03)

aOR, adjusted odds ratio; CI, confidence interval

a: Q1 is the lowest quintile. Q5 is the highest quintile.

b: Adjusted for maternal age, place of recruitment, maternal height, pre-pregnant BMI, maternal weight gain during pregnancy, parity, conception method (assisted reproductive technology or not), pre-existing maternal hypertension, pre-existing maternal diabetes, parental allergic history, parental smoking, maternal education, maternal household income, infant gender, maternal folic acid supplementation during pregnancy, breastfeeding at one month after delivery, estimated maternal total energy intake during pregnancy, and delivery mode (vaginal or cesarean)

The association between maternal dietary intake of nutrients related to vegetables and allergic outcomes is shown in Table 3. As with vegetable intake, the aORs per quintile of maternal nutrient intake for all allergic outcomes were close to 1.0 (range: 0.87 to 1.13) compared with the lowest quintile. Crude and multivariate analyses showed a similar association in terms of both vegetables and related nutrients. Detailed data on the number of each quintile of vegetables and nutrients for the outcomes of interest are shown in S1 Table. The results of the crude analysis are shown in S2 Table.

Table 3. Association between maternal nutritional intake and allergic diseases in offspring.

Maternal intakea Asthma Wheeze Atopic dermatitis Eczema Food allergy Any allergy
aORb aOR aOR aOR aOR aOR
Vitamin A (μg/day)
Q1 (240.5±19.3) reference reference reference reference reference reference
Q2 (353.0±187.4) 0.91 (0.78–1.05) 0.97 (0.91–1.03) 0.89 (0.79–1.00) 1.00 (0.94–1.06) 1.09 (1.02–1.16) 1.04 (0.99–1.10)
Q3 (449.7±247.1) 0.87 (0.76–1.03) 0.98 (0.92–1.04) 0.90 (0.80–1.01) 1.04 (0.98–1.10) 1.07 (1.01–1.14) 1.06 (1.00–1.11)
Q4 (584.4±330.6) 0.89 (0.76–1.03) 0.99 (0.93–1.05) 0.89 (0.80–1.00) 1.03 (0.97–1.10) 1.08 (1.01–1.15) 1.05 (1.00–1.11)
Q5 (1053.6±1265.4) 0.88 (0.76–1.02) 1.02 (0.96–1.08) 0.93 (0.83–1.05) 1.03 (0.97–1.10) 1.00 (0.94–1.07) 1.01 (0.96–1.07)
Alpha-carotene (μg/day)
Q1 (102.8±81.4) reference reference reference reference reference reference
Q2 (255.7±106.7) 1.01 (0.87–1.18) 0.98 (0.92–1.04) 0.99 (0.88–1.11) 1.04 (0.98–1.11) 1.07 (1.01–1.14) 1.05 (1.00–1.11)
Q3 (377.4±190.7) 1.00 (0.86–1.17) 1.04 (0.98–1.11) 0.95 (0.85–1.07) 1.00 (0.94–1.06) 1.10 (1.03–1.17) 1.03 (0.98–1.09)
Q4 (581.8±215.6) 1.09 (0.93–1.27) 1.03 (0.97–1.10) 1.00 (0.89–1.12) 1.08 (1.02–1.15) 1.08 (1.01–1.15) 1.10 (1.04–1.16)
Q5 (1061.2±948.3) 0.95 (0.81–1.11) 0.99 (0.93–1.05) 1.03 (0.92–1.16) 1.10 (1.03–1.16) 1.10 (1.04–1.18) 1.09 (1.03–1.15)
Beta-carotene (μg)/day
Q1 (1127.6±771.4) reference reference reference reference reference reference
Q2 (1966.5±895.1) 0.89 (0.77–1.04) 1.01 (0.95–1.08) 0.94 (0.83–1.06) 1.01 (0.95–1.07) 1.06 (1.00–1.13) 1.01 (0.96–1.07)
Q3 (2678.3±1247.3) 1.01 (0.87–1.17) 1.05 (0.98–1.11) 1.00 (0.89–1.12) 1.01 (0.95–1.08) 1.08 (1.01–1.15) 1.05 (0.99–1.10)
Q4 (3508.8±1398.7) 0.96 (0.83–1.12) 1.02 (0.96–1.08) 1.00 (0.89–1.13) 1.08 (1.01–1.14) 1.07 (1.01–1.15) 1.07 (1.02–1.13)
Q5 (5753.5±4278.8) 0.94 (0.81–1.10) 1.02 (0.96–1.09) 1.05 (0.94–1.18) 1.08 (1.02–1.15) 1.06 (0.99–1.13) 1.06 (1.00–1.11)
Vitamin C (mg/day)
Q1 (39.0±25.2) reference reference reference reference reference reference
Q2 (61.5±26.8) 1.00 (0.86–1.16) 1.05 (0.99–1.11) 0.97 (0.86–1.09) 1.07 (1.01–1.14) 1.07 (1.00–1.14) 1.06 (1.01–1.12)
Q3 (81.5±41.3) 1.00 (0.86–1.17) 1.05 (0.99–1.12) 1.03 (0.91–1.15) 1.03 (0.97–1.10) 1.07 (1.01–1.14) 1.05 (1.00–1.11)
Q4 (102.9±47.2) 1.07 (0.92–1.25) 1.04 (0.98–1.11) 1.08 (0.96–1.22) 1.07 (1.00–1.13) 1.05 (0.99–1.12) 1.06 (1.00–1.11)
Q5 (157.1±98.3) 1.02 (0.88–1.19) 1.08 (1.01–1.14) 1.10 (0.98–1.23) 1.08 (1.01–1.15) 1.00 (0.93–1.06) 1.04 (0.98–1.09)
Alpha-tocopherol (mg/day)
Q1 (4.2±2.3) reference reference reference reference reference reference
Q2 5.4±2.3) 1.01 (0.87–1.16) 1.01 (0.95–1.07) 1.03 (0.92–1.16) 1.01 (0.95–1.07) 1.02 (0.96–1.09) 1.00 (0.95–1.05)
Q3 (6.2±2.5) 1.03 (0.89–1.19) 1.01 (0.95–1.07) 1.07 (0.96–1.21) 1.02 (0.96–1.08) 1.04 (0.97–1.10) 1.03 (0.98–1.08)
Q4 (7.1±3.2) 0.88 (0.76–1.04) 1.00 (0.94–1.07) 1.03 (0.92–1.16) 1.05 (0.99–1.12) 1.07 (1.00–1.13) 1.04 (0.99–1.10)
Q5 (9.3±5.5) 0.89 (0.76–1.04) 1.02 (0.96–1.08) 1.08 (0.96–1.21) 1.05 (0.99–1.12) 1.05 (0.98–1.12) 1.01 (0.96–1.07)
Vitamin K (μg/day)
Q1 (82.2±50.4) reference reference reference reference reference reference
Q2 (129.7±60.9) 1.06 (0.91–1.23) 1.04 (0.98–1.10) 0.99 (0.89–1.12) 1.03 (0.97–1.10) 1.04 (0.98–1.11) 1.03 (0.98–1.09)
Q3 (167.3±75.3) 1.06 (0.91–1.24) 1.01 (0.95–1.08) 0.97 (0.86–1.09) 1.01 (0.95–1.08) 1.01 (0.95–1.08) 1.01 (0.96–1.06)
Q4 (221.8±105.1) 1.00 (0.85–1.16) 1.03 (0.97–1.10) 1.10 (0.98–1.24) 1.03 (0.97–1.10) 1.04 (0.98–1.11) 1.02 (0.97–1.07)
Q5 (358.9±255.6) 1.02 (0.87–1.19) 1.00 (0.94–1.07) 0.98 (0.87–1.10) 1.02 (0.96–1.09) 0.99 (0.92–1.05) 0.98 (0.93–1.04)
Folate (μg/day)
Q1 (158.2±873.9) reference reference reference reference reference reference
Q2 (210.6±92.4) 0.88 (0.76–1.03) 1.02 (0.96–1.08) 0.92 (0.82–1.04) 1.06 (1.00–1.13) 1.02 (0.96–1.08) 1.03 (0.98–1.08)
Q3 (247.8±100.4) 0.96 (0.83–1.12) 1.02 (0.96–1.08) 0.99 (0.88–1.12) 1.08 (1.02–1.15) 1.02 (0.96–1.09) 1.03 (0.98–1.09)
Q4 (293.8±134.1) 0.99 (0.85–1.15) 1.03 (0.97–1.10) 1.05 (0.93–1.17) 1.06 (1.00–1.13) 0.99 (0.93–1.05) 1.02 (0.97–1.08)
Q5 (394.6±230.0) 0.93 (0..80–1.09) 1.07 (1.00–1.13) 1.04 (0.93–1.17) 1.08 (1.01–1.15) 0.96 (0.90–1.03) 1.00 (0.95–1.05)
Soluble fiber (g/day)
Q1 (1.5±0.7) reference reference reference reference reference reference
Q2 (2.0±0.7) 0.98 (0.85–1.14) 1.02 (0.96–1.08) 0.98 (0.87–1.11) 1.03 (0.97–1.10) 1.04 (0.98–1.11) 1.04 (0.98–1.09)
Q3 (2.4±0.9) 0.96 (0.82–1.12) 1.00 (0.94–1.06) 1.09 (0.97–1.22) 1.10 (1.04–1.17) 0.94 (0.89–1.01) 1.00 (0.95–1.06)
Q4 (2.9±1.0) 1.04 (0.90–1.21) 1.04 (0.98–1.11) 1.09 (0.97–1.23) 1.09 (1.03–1.16) 1.02 (0.96–1.09) 1.05 (1.00–1.11)
Q5 (4.3±2.6) 1.01 (0.86–1.18) 1.01 (0.94–1.07) 1.09 (0.97–1.22) 1.14 (1.07–1.21) 1.02 (0.95–1.09) 1.07 (1.01–1.12)
Insoluble fiber (g/day)
Q1 (5.0±2.3) reference reference reference reference reference reference
Q2 (6.2±2.3) 0.95 (0.82–1.11) 0.97 (0.92–1.03) 1.00 (0.89–1.13) 1.07 (1.00–1.13) 1.02 (0.96–1.08) 1.04 (0.99–1.09)
Q3 (7.3±2.6) 1.01 (0.87–1.18) 1.00 (0.94–1.06) 0.98 (0.87–1.11) 1.07 (1.00–1.13) 0.99 (0.93–1.05) 1.03 (0.98–1.08)
Q4 (8.6±3.2) 1.00 (0.86–1.16) 1.00 (0.94–1.06) 1.08 (0.96–1.21) 1.11 (1.04–1.18) 0.99 (0.93–1.06) 1.05 (0.99–1.10)
Q5 (11.8±6.8) 0.98 (0.83–1.14) 1.01 (0.95–1.07) 1.08 (0.96–1.21) 1.12 (1.05–1.19) 1.00 (0.93–1.06) 1.04 (0.99–1.10)
Total fiber (g/day)
Q1 (6.8±3.2) reference reference reference reference reference reference
Q2 (8.7±3.3) 1.01 (0.87–1.18) 1.01 (0.96–1.08) 1.03 (0.92–1.16) 1.07 (1.01–1.14) 1.04 (0.97–1.10) 1.06 (1.01–1.12)
Q3 (10..3±3.9) 0.97 (0.83–1.13) 1.01 (0.95–1.08) 1.01 (0.90–1.14) 1.06 (1.00–1.13) 0.96 (0.91–1.03) 1.02 (0.97–1.07)
Q4 (12.0±4.5) 1.05 (0.90–1.22) 1.00 (0.94–1.06) 1.09 (0.97–1.22) 1.10 (1.03–1.17) 1.02 (0.96–1.08) 1.06 (1.00–1.11)
  Q5 (16.4±9.6) 0.97 (0.83–1.14) 1.03 (0.96–1.09) 1.08 (0.96–1.21) 1.13 (1.06–1.20) 1.01 (0.95–1.08) 1.06 (1.01–1.12)

a: Q1 is the lowest quintile. Q5 is the highest quintile.

b: Adjusted for maternal age, place of recruitment, maternal height, pre-pregnant BMI, maternal weight gain during pregnancy, parity, conception method (assisted reproductive technology or not), pre-existing maternal hypertension, pre-existing maternal diabetes, parental allergic history, parental smoking, maternal education, maternal household income, infant gender, maternal folic acid supplementation during pregnancy, breastfeeding at one month after delivery, estimated maternal total energy intake during pregnancy, and delivery mode (vaginal or cesarean)

The results of a sensitivity analysis using multiple imputations for the missing data are shown in S3 Table. The association observed in the sensitivity analysis was similar to that observed in the main analysis of cases with complete data. The results of the additional analysis of the association between maternal allergic history and vegetable intake are shown in S4 Table. There was no substantial difference in maternal allergic history among the categories when assessed by maternal vegetable intake.

Discussion

This study found no clear association between the maternal intake of vegetables and related nutrients with the development of asthma or wheezing among offspring at one year of age. Furthermore, our study demonstrated that neither factor contributed to any difference in the risk of atopic dermatitis, eczema, or food allergy.

The present study is the largest of its kind to examine the association between maternal vegetable intake during pregnancy and the development of allergic diseases in offspring at one year of old. While previous studies on the association of maternal vegetable intake with asthma or wheezing in offspring have yielded inconsistent results [914, 29, 30], our study, using a larger sample, was unable to find substantial differences in the risk of allergic disease development. One reason for this discrepancy might be the difference in the timeframes for assessing maternal dietary intake, as several studies have shown that maternal exposure during specific pregnancy periods is associated with allergic outcomes in offspring [9, 3133]. Although a study on Japanese women showed that a significant, inverse association between maternal vegetable intake and wheeze in offspring appeared only in early pregnancy [9], most studies did not focus on a specific timeframe for assessing exposure. However, a more likely explanation of these differences is the timing of the outcome assessments. Two studies on wheeze in offspring during the first year of life showed a non-significant association [12, 13], and some studies on older children showed a significant, inverse association [10, 29, 30], suggesting that maternal vegetable intake is not associated with asthma development during the first year of life. As infant wheezing, which is mainly caused by viral infections, and atopic asthma are uncommon in young infants, the present study’s findings suggest that maternal vegetable intake may not be associated with the etiology of infant wheeze. However, wheeze and asthma at one year of age do not necessarily have the same etiology as when they appear later in life [34], leaving much yet to be clarified on the etiology of these conditions in children.

A few prospective studies that investigated the association between maternal vegetable intake during pregnancy and eczema in offspring produced inconsistent results [10, 11, 13]. Two studies attributed a significant association between them, while one study demonstrated that women with a higher vegetable intake during pregnancy were more likely to have offspring without atopic dermatitis at the age of 6.5 years [10]. Another study demonstrated a significant inverse association between maternal green and yellow vegetable intake during pregnancy and the development of eczema in offspring aged 16–24 months [11]. Two studies, one examining eczema development at one year of age [13] and the other examining eczema development at two years of age [14], showed a non-significant association between maternal vegetable intake and eczema development. Our results indicate the absence of a substantial risk for eczema development during the first year of life in offspring regardless of the category of maternal vegetable intake during pregnancy, suggesting that the association between maternal vegetable intake and eczema development depends on the age of the offspring, as seen in wheeze and asthma development in offspring at one year of age.

The present study also suggests that women with a higher intake of total vegetables, folate-rich vegetables, green and yellow vegetables, and certain nutrients have a slightly higher risk of their offspring developing eczema and food allergy. Although the reasons for this slightly elevated risk are difficult to ascertain; environmental factors, such as the presence of pesticide residues on produce grown in Japan, might provide an explanation. While no study has investigated the association between early-life exposure to pesticides and atopic dermatitis development in childhood, some studies have demonstrated a significant, positive association between pesticide exposure and the development of childhood asthma [3537]. As childhood asthma, food allergy, and atopic dermatitis are part of the allergy march [38], atopic changes might be followed by food allergy and asthma as a consequence of prenatal exposure to unidentified environmental factors. Our results found no positive association between vegetable intake during pregnancy and asthma/wheeze or eczema in offspring; this may be due to the difficulty of assessing asthma outcomes at one year of age, as discussed above. Thus, future research on these topics is required.

Most previous studies on vitamin A, C, and E reported a non-significant association with allergic outcomes [4], while one study reported a significant inverse association between maternal vitamin E intake and childhood wheeze [39]. Studies of maternal folate intake have shown mixed results on its association with wheeze and asthma [40, 41], and none have demonstrated a significant association with eczema or atopic dermatitis [42, 43]. Our study demonstrated that maternal vitamin and folate intake did not have a substantial association with allergic outcomes, including asthma, wheeze, eczema, and food allergy, in offspring. The relatively young age of the offspring examined in this study may be another reason for our findings. On the other hand, no studies have yet investigated the possibility of an association between maternal dietary fiber intake and allergic disease in offspring, despite a recent study suggesting that the metabolism of dietary fiber may influence the development of allergic diseases of the airway [44]. At any rate, the current study found no substantial association, in line with studies of other nutrients.

The strength of our study includes the large sample size, which enabled the accurate assessment of the association between dietary intake and allergic outcomes as well as sufficient adjustment for potential confounders. We also confirmed the validity of the FFQ used in the current study because the mean EI/BMR in our samples was 1.52 (data not shown) [45]. Furthermore, although our sample included cases with missing information, a sensitivity analysis with an imputed dataset was used to confirm the accuracy of the data. We believe that this study presents a reliable result on the association between maternal vegetable intake during pregnancy and allergic outcomes in offspring at one year of age. Nonetheless, this study has several limitations. First, allergies appearing at one year of age do not always continue into later life [34, 46] despite allergic disorders at this age being a risk factor for subsequent allergic disease development. Further longitudinal studies investigating the association between maternal vegetable intake during pregnancy and the development of allergic disease in offspring using the same birth cohort over a longer follow-up period are warranted. Second, the FFQ used in the current study was validated for use with the general population but not with pregnant women [21, 22]. Furthermore, misclassification of dietary intake, which could lead to underestimation, may have occurred as the FFQ was self-reported. Third, although previous studies have used asthma, atopic dermatitis, and food allergy based on the doctor’s diagnosis as outcome variables [47, 48], these have not been validated. However, we complementally used those variables in addition to wheeze and eczema using a questionnaire because the assessment of allergic outcomes in offspring at one year of age is challenging. There may also have been some misclassification risk using two tools for the outcome assessment (self-reported questionnaire and doctor’s diagnosis).

Conclusions

The present study demonstrated non-substantial differences in the risk of asthma, wheeze, atopic dermatitis, eczema, and food allergy development in offspring at one year of age due to maternal intake of vegetables and related nutrients.

Supporting information

S1 Table. Number of each quintile of vegetables and nutrients for the outcomes of interest.

(DOCX)

S2 Table. Crude odds ratio of the allergic outcomes between quintiles for each exposure category.

(DOCX)

S3 Table. Association between maternal nutritional intake and allergic disease in offspring based on the imputed data set.

(DOCX)

S4 Table. Relationship between maternal vegetable intake and maternal allergic history.

(DOCX)

Acknowledgments

We are grateful to all the participants and individuals involved in the data collection. We would also like to thank the following members of the JECS as of 2019: Michihiro Kamijima (principal investigator, Nagoya City University, Nagoya, Japan), Shin Yamazaki (National Institute for Environmental Studies, Tsukuba, Japan), Yukihiro Ohya (National Center for Child Health and Development, Tokyo, Japan), Reiko Kishi (Hokkaido University, Sapporo, Japan), Nobuo Yaegashi (Tohoku University, Sendai, Japan), Koichi Hashimoto (Fukushima Medical University, Fukushima, Japan), Chisato Mori (Chiba University, Chiba, Japan), Shuichi Ito (Yokohama City University, Yokohama, Japan), Zentaro Yamagata (University of Yamanashi, Chuo, Japan), Hidekuni Inadera (University of Toyama, Toyama, Japan), Takeo Nakayama (Kyoto University, Kyoto, Japan), Hiroyasu Iso (Osaka University, Suita, Japan), Masayuki Shima (Hyogo College of Medicine, Nishinomiya, Japan), Youichi Kurozawa (Tottori University, Yonago, Japan), Narufumi Suganuma (Kochi University, Nankoku, Japan), Koichi Kusuhara (University of Occupational and Environmental Health, Kitakyushu, Japan), and Takahiko Katoh (Kumamoto University, Kumamoto, Japan). We would also like to thank James R. Valera of the Department of Education for Clinical Research of the National Center for Child Health and Development for his assistance in editing this manuscript.

Data Availability

Data are unsuitable for public deposition due to ethical restrictions and legal framework of Japan. It is prohibited by the Act on the Protection of Personal Information (Act No.57 of 30 May 2003, amendment on 9 September 2015) to publicly deposit the data containing personal information. Ethical Guidelines for Epidemiological Research enforced by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare also restricts the open sharing of the epidemiologic data. All inquiries about access to data should be sent to: jecs-en@nies.go.jp. The person responsible for handling enquiries sent to this e-mail address is Dr Shoji F. Nakayama, JECS Programme Office, National Institute for Environmental Studies.

Funding Statement

The JECS was funded by the Ministry of the Environment, Japan. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the Japanese government.

References

  • 1.Castro-Rodriguez JA, Forno E, Rodriguez-Martinez CE, Celedón JC. Risk and protective factors for childhood asthma: what is the evidence? J Allergy Clin Immunol Pract. 2016;4(6): 1111–1122. 10.1016/j.jaip.2016.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chiesa Fuxench ZC. Atopic dermatitis: disease background and risk factors. Adv Exp Med Biol. 2017;1027: 11–19. 10.1007/978-3-319-64804-0_2 [DOI] [PubMed] [Google Scholar]
  • 3.Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol. 2006;6(11): 869–874. 10.1038/nri1958 [DOI] [PubMed] [Google Scholar]
  • 4.Beckhaus AA, Garcia-Marcos L, Forno E, Pacheco-Gonzalez RM, Celedón JC, Castro-Rodriguez JA. Maternal nutrition during pregnancy and risk of asthma, wheeze, and atopic diseases during childhood: a systematic review and meta-analysis. Allergy. 2015;70(12): 1588–1604. 10.1111/all.12729 [DOI] [PubMed] [Google Scholar]
  • 5.Varraso R. Nutrition and asthma. Curr Allergy Asthma Rep. 2012;12(3): 201–210. 10.1007/s11882-012-0253-8 [DOI] [PubMed] [Google Scholar]
  • 6.Allan K, Devereux G. Diet and asthma: nutrition implications from prevention to treatment. J Am Diet Assoc. 2011;111(2): 258–268. 10.1016/j.jada.2010.10.048 [DOI] [PubMed] [Google Scholar]
  • 7.Harasym J, Oledzki R. Effect of fruit and vegetable antioxidants on total antioxidant capacity of blood plasma. Nutrition. 2014;30(5): 511–517. 10.1016/j.nut.2013.08.019 [DOI] [PubMed] [Google Scholar]
  • 8.Zhu F, Du B, Xu B. Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: a review. Crit Rev Food Sci Nutr. 2018;58(8): 1260–1270. 10.1080/10408398.2016.1251390 [DOI] [PubMed] [Google Scholar]
  • 9.Ogawa K, Morisaki N, Kobayashi M, Jwa SC, Tani Y, Sago H, et al. Maternal vegetable intake in early pregnancy and wheeze in offspring at the age of 2 years. Eur J Clin Nutr. 2018;72(5): 761–771. 10.1038/s41430-018-0102-5 [DOI] [PubMed] [Google Scholar]
  • 10.Chatzi L, Torrent M, Romieu I, Garcia-Esteban R, Ferrer C, Vioque J, et al. Mediterranean diet in pregnancy is protective for wheeze and atopy in childhood. Thorax. 2008;63(6): 507–513. 10.1136/thx.2007.081745 [DOI] [PubMed] [Google Scholar]
  • 11.Miyake Y, Sasaki S, Tanaka K, Hirota Y. Consumption of vegetables, fruit, and antioxidants during pregnancy and wheeze and eczema in infants. Allergy. 2010;65(6): 758–765. 10.1111/j.1398-9995.2009.02267.x [DOI] [PubMed] [Google Scholar]
  • 12.Willers SM, Wijga AH, Brunekreef B, Kerkhof M, Gerritsen J, Hoekstra MO, et al. Maternal food consumption during pregnancy and the longitudinal development of childhood asthma. Am J Respir Crit Care Med. 2008;178(2): 124–131. 10.1164/rccm.200710-1544OC [DOI] [PubMed] [Google Scholar]
  • 13.Chatzi L, Garcia R, Roumeliotaki T, Basterrechea M, Begiristain H, Iñiguez C, et al. Mediterranean diet adherence during pregnancy and risk of wheeze and eczema in the first year of life: INMA (Spain) and RHEA (Greece) mother–child cohort studies. Br J Nutr. 2013;110(11): 2058–2068. 10.1017/S0007114513001426 [DOI] [PubMed] [Google Scholar]
  • 14.Oien T, Storrø O, Johnsen R. Do early intake of fish and fish oil protect against eczema and doctor-diagnosed asthma at 2 years of age? A cohort study. J Epidemiol Community Health. 2010;64(2): 124–129. 10.1136/jech.2008.084921 [DOI] [PubMed] [Google Scholar]
  • 15.Kawamoto T, Nitta H, Murata K, Toda E, Tsukamoto N, Hasegawa M, et al. Rationale and study design of the Japan environment and children’s study (JECS). BMC Public Health. 2014;14: 25 10.1186/1471-2458-14-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Michikawa T, Nitta H, Nakayama SF, Yamazaki S, Isobe T, Tamura K, et al. Baseline profile of participants in the Japan environment and children’s study (JECS). J Epidemiol. 2018;28(2): 99–104. 10.2188/jea.JE20170018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Saito M, Yamamoto-Hanada K, Pak K, Ayabe T, Mezawa H, Ishitsuka K, et al. Having small-for-gestational-age infants was associated with maternal allergic features in the JECS birth cohort. Allergy. 2018;73(9): 1908–1911. 10.1111/all.13490 [DOI] [PubMed] [Google Scholar]
  • 18.Yamamoto-Hanada K, Ishitsuka K, Pak K, Saito M, Ayabe T, Mezawa H, et al. Allergy and mental health among pregnant women in the Japan Environment and children’s Study. J Allergy Clin Immunol Pract. 2018;6(4): 1421–1424.e2. 10.1016/j.jaip.2017.12.006 [DOI] [PubMed] [Google Scholar]
  • 19.Ministry of Health Law. Ethical guidelines for medical and Health Research involving human subjects Tokyo: Ministry of Health, Labor and Welfare; 2015. [cited 2020 December, 8]. Available from https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf [Google Scholar]
  • 20.Ishitsuka K, Sasaki S, Yamamoto-Hanada K, Mezawa H, Konishi M, Ohya Y, et al. Changes in dietary intake in pregnant women from periconception to pregnancy in the Japan environment and children’s study: a nationwide Japanese birth cohort study. Matern Child Health J. 2020;24(3): 389–400. 10.1007/s10995-019-02835-z [DOI] [PubMed] [Google Scholar]
  • 21.Sasaki S, Ishihara J, Tsugane S, J PHC. Reproducibility of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess food and nutrient intake. J Epidemiol. 2003;13(1): S115–124. 10.2188/jea.13.1sup_115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tsugane S, Kobayashi M, Sasaki S, J PHC. Validity of the self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I: comparison with dietary records for main nutrients. J Epidemiol. 2003;13(1): S51–56. 10.2188/jea.13.1sup_51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yokoyama Y, Takachi R, Ishihara J, Ishii Y, Sasazuki S, Sawada N, et al. Validity of short and long self-administered food frequency questionnaires in ranking dietary intake in middle-aged and elderly Japanese in the Japan Public Health Center-Based Prospective Study for the Next Generation (JPHC-NEXT) protocol area. J Epidemiol. 2016;26(8): 420–432. 10.2188/jea.JE20150064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ministry of Education Culture S, Science & Technology in Japan. Standard tables of food composition in Japan 2010. 2010.
  • 25.Jenkins MA, Clarke JR, Carlin JB, Robertson CF, Hopper JL, Dalton MF, et al. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol. 1996;25(3): 609–616. 10.1093/ije/25.3.609 [DOI] [PubMed] [Google Scholar]
  • 26.Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103(1 Pt. 1): 125–38. 10.1016/s0091-6749(99)70536-1 [DOI] [PubMed] [Google Scholar]
  • 27.Nurmatov U, Nwaru BI, Devereux G, Sheikh A. Confounding and effect modification in studies of diet and childhood asthma and allergies. Allergy. 2012;67(8): 1041–1059. 10.1111/j.1398-9995.2012.02858.x [DOI] [PubMed] [Google Scholar]
  • 28.Willet WC. Nutritional epidemiology. 2nd ed New York: Oxford University Press; 1998. [Google Scholar]
  • 29.Erkkola M, Nwaru BI, Kaila M, Kronberg-Kippilä C, Ilonen J, Simell O, et al. Risk of asthma and allergic outcomes in the offspring in relation to maternal food consumption during pregnancy: a Finnish birth cohort study. Pediatr Allergy Immunol. 2012;23(2): 186–194. 10.1111/j.1399-3038.2012.01272.x [DOI] [PubMed] [Google Scholar]
  • 30.Fitzsimon N, Fallon U, O’Mahony D, Loftus BG, Bury G, Murphy AW, et al. Mothers’ dietary patterns during pregnancy and risk of asthma symptoms in children at 3 years. Ir Med J. 2007;100(8 suppl): 27–32. [PubMed] [Google Scholar]
  • 31.Chu S, Yu H, Chen Y, Chen Q, Wang B, Zhang J. Periconceptional and gestational exposure to antibiotics and childhood asthma. PLOS One. 2015;10(10): e0140443 10.1371/journal.pone.0140443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Håberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child. 2009;94(3): 180–184. 10.1136/adc.2008.142448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Veeranki SP, Gebretsadik T, Mitchel EF, Tylavsky FA, Hartert TV, Cooper WO, et al. Maternal folic acid supplementation during pregnancy and early childhood asthma. Epidemiology. 2015;26(6): 934–941. 10.1097/EDE.0000000000000380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics. 2002;109(2 Suppl): 362–367. [PubMed] [Google Scholar]
  • 35.Raanan R, Harley KG, Balmes JR, Bradman A, Lipsett M, Eskenazi B. Early-life exposure to organophosphate pesticides and pediatric respiratory symptoms in the CHAMACOS cohort. Environ Health Perspect. 2015;123(2): 179–185. 10.1289/ehp.1408235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Salam MT, Li YF, Langholz B, Gilliland FD, Children's Health Study. Early-life environmental risk factors for asthma: findings from the children’s Health Study. Environ Health Perspect. 2004;112(6): 760–765. 10.1289/ehp.6662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Salameh PR, Baldi I, Brochard P, Raherison C, Abi Saleh B, Salamon R. Respiratory symptoms in children and exposure to pesticides. Eur Respir J. 2003;22(3): 507–512. 10.1183/09031936.03.00107403a [DOI] [PubMed] [Google Scholar]
  • 38.Hahn EL, Bacharier LB. The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am. 2005;25(2): 231–246. 10.1016/j.iac.2005.02.004 [DOI] [PubMed] [Google Scholar]
  • 39.Litonjua AA, Rifas-Shiman SL, Ly NP, Tantisira KG, Rich-Edwards JW, Camargo CA Jr., et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006;84(4): 903–911. 10.1093/ajcn/84.4.903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Granell R, Heron J, Lewis S, Davey Smith G, Sterne JA, Henderson J. The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort. Clin Exp Allergy. 2008;38(2): 320–328. 10.1111/j.1365-2222.2007.02902.x [DOI] [PubMed] [Google Scholar]
  • 41.Veeranki SP, Gebretsadik T, Dorris SL, Mitchel EF, Hartert TV, Cooper WO, et al. Association of folic acid supplementation during pregnancy and infant bronchiolitis. Am J Epidemiol. 2014;179(8): 938–946. 10.1093/aje/kwu019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bekkers MB, Elstgeest LE, Scholtens S, Haveman-Nies A, de Jongste JC, Kerkhof M, et al. Maternal use of folic acid supplements during pregnancy, and childhood respiratory health and atopy. Eur Respir J. 2012;39(6): 1468–1474. 10.1183/09031936.00094511 [DOI] [PubMed] [Google Scholar]
  • 43.Magdelijns FJ, Mommers M, Penders J, Smits L, Thijs C. Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics. 2011;128(1): e135–144. 10.1542/peds.2010-1690 [DOI] [PubMed] [Google Scholar]
  • 44.Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2): 159–166. 10.1038/nm.3444 [DOI] [PubMed] [Google Scholar]
  • 45.Black AE. Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Relat Metab Disord. 2000;24(9): 1119–1130. 10.1038/sj.ijo.0801376 [DOI] [PubMed] [Google Scholar]
  • 46.Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy. 2018;73(3): 696–704. 10.1111/all.13320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Yamamoto-Hanada K, Yang L, Ishitsuka K, Ayabe T, Mezawa H, Konishi M, et al. Allergic profiles of mothers and fathers in the Japan Environment and Children’s Study (JECS): a nationwide birth cohort study. World Allergy Organ J. 2017;10(1): 24 10.1186/s40413-017-0157-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Yamamoto-Hanada K, Pak K, Saito-Abe M, Yang L, Sato M, Mezawa H, et al. Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan. Environ Health Prev Med. 2020;25(1): 27 10.1186/s12199-020-00864-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Calistus Wilunda

7 Oct 2020

PONE-D-20-22340

Association between maternal vegetable intake during pregnancy and allergy in offspring: Japan Environment and Children's Study (JECS).

PLOS ONE

Dear Dr. kohei,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 21 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Calistus Wilunda, DrPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. One of the noted authors is a group or consortium [Japan Environment and Children’s Study (JECS) Group^]. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This novel paper investigates the potential association between maternal intake of vegetables during pregnancy and the risk of a range of childhood allergic diseases. The paper seek to add new knowledge to inconsistent results on this specific topic being conducting analyses in a large well conducted and well described young cohort. The authors apply appropriate statistical models and present a range of results, which are presented in a simple concise way. However, the authors could consider an alternative presentation of results in table 3. I have only a range of minor comments and some considerations, which could be added to the discussion.

Minor comments

Abstract:

Please add in relation to the aOR, 95% confidence intervals (95%CI) in the methods, and the results. And add the 95%CI to the presentation of results.

Introduction:

Who has stated that “maternal vegetable intake during pregnancy is one of the most interesting exposures? Please, reconsider the use of “most interesting”

It would be relevant to add a few words on proposed mechanisms of the anti-oxidative and anti-inflammatory properties in relation to development of immune responses potentially working during fetal life – which later maybe related to development of allergic diseases.

Please, add to the description of previous studies, the type of studies and range of n in the “relatively small sample sizes”.

Did any of the studies showing a positive association between vegetables and allergic diseases use register data or self-reported questionnaire data? Please, add a bit more information on these studies which can be used for discussion later.

Materials and methods:

Line 89, In the method section, please add information in which gestational weeks the FFQ was completed.

Line 95-97: it is unclear whether women who were missing information in one variable only was excluded or not. Is it correct those women who were missing values on every outcome, were excluded – not if they were missing values in one or two, then they were kept in the analyses? Nevertheless, in line 97 the analyses used a complete dataset – meaning no missing values at all? Maybe change wording to ‘missing values on one or more outcomes’ if that were the case.

Line 98: please add number of observations in the multiple imputation data set.

Line 102: is it possible to add a reference to the “other nationally valid regulations”?

Line 106: please add mean gestational weeks of when the FFQ was completed during pregnancy.

Line 107: what does the authors mean by ‘other profiles’? Please, add sufficient information in the text.

Regarding vegetables groups: Please, explain the rationale for having spinach in two groups. What are the pros and cons? Please, if any cons could influence the observed associations or interpretations of results, this should be included in the discussion.

Line 125: Please, add one sentence on the validity of the ISSAC tool

Line 130: has the doctor’s diagnosis been validated at some point? How well is coverage of cases using the doctor diagnosis?

Is there a risk of misclassification using these two tools for outcome assessments?

Line 142: Please, add a sentence that the covariates were selected based on previous literature, which seems to be the case.

Line 146+148: there are some uncertainity about the numbers. The remaining 80,270 do have missing data, not on all outcomes but maybe some? Please, add n for the dataset used for the amin analysis with ‘women with no missing data’ and those ‘in the multiple imputation sensitivity analyses’

The wording “ a quintile base on the energy-adjusted estimate of the intake for total vegetables” does not seem correct and is difficult to understand. Please reconsider this sentence and title for Figure 1.

Table 1. In some lines, n(%) has been added to the test e.g. “Junior high school” but not by others e.g. “maternal allergic history” etc. Please, consider to be more consistent.

Maybe say “Allergic disorder at age 1” instead of “at endpoint”

Line 184: “for other kinds of vegetables” are to unspecific. Which vegetables are the authors referring to?

Table 2 and 3. Please, try to make each column fit the text in a way that the results aOR (95%CI) can fit in one line. Makes it easier to read.

In the foot note, has ‘ART’ been written fully. I think, the authors should also write fully in a foot note.

Please, add that the unit is per day? Vitamin A ug/day. Also please, add n.

Would it be possible to makes figures or the like of (some) results in table 3? This tables is rather long across several pages.

The discussion:

The authors, briefly discuss the timing of the FFQ in relation to observed findings. However, is the timing relevant in relation to the development of auto immune responses in fetal life? And is the timing irrelevant since ‘most other studies did not focus on the time frame’?

The authors could discuss in more depth the ‘difficulties in assessing the asthma outcomes at age 1. Please see my questions above on the validity of outcome assessment, proc&cons

Did any of the studies showing a positive association between vegetables and allergic diseases use register data or self-reported questionnaire data?

How did the present study obtain the goal of being able to add significant knowledge to the existing knowledge base with this larger cohort study?

Line 240: what is the prevalence of wheeze and asthma in older children?

Line 277: does the authors mean? “using similar birth cohorts” or “using the same birth cohort with longer follow-up”?

How would misclassification of dietary intake by the FFQ affect the observed associations? Please, add a sentence to the discussion.

Reviewer #2: Dear authors,

This is a very interesting paper investigating the associations between maternal diet during pregnancy and allergic diseases in the offspring at age 1.

My main concern is the fact that the analysis were performed without adjusting on maternal breastfeeding, which can be a vety important factor in allergic diseases.

I would also suggest to adjust on maternal supplementation during pregnancy.

My minor concern is : page 7, line 88 : please delete "the" before maternal.

Reviewer #3: This paper aim at assessing the association between maternal intake of vegetables and related nutrients during pregnancy with allergic diseases in offspring at age 1 year. In order to reach this aim the authors use the information provided by a cohort study on a large sample of pregnant women. The information on dietary exposures was collected by means of a Food Frequency Questionnaire, whereas health outcomes in the offspring at age 1 year through the International Study of Asthma and Allergies in Childhood questionnaire.

The authors state that maternal intake of vegetables and other related nutrients during pregnancy had little or no association with the considered health outcomes in offspring at age 1 year.

The paper is well written and the authors have in general used proper methods to analyze their data. However, I would like to seek clarification on some points.

- Did the author perform some form of quality check on the FFQ questionnaire (for example: did they drop subjects with implausible values of estimated energy? Did they evaluate the ratio of energy intake to basal metabolic rate?)?

- Due to the poor quality of the image, I could not properly understand the utility of figure 1. What does figure 1 add to the text to explain how the authors created energy-adjusted quintiles of maternal vegetable intakes/related nutrients? Maybe some important details of the statistical model could be enlightened by this figure.

- The authors consider several covariates in the multivariate models. Among these covariates total energy intake is not present. Why? Even when the residual method is used, it is generally recommended to include total energy intake as a covariate in the model (see 1. Willet WC. Nutritional epidemiology 2nd ed. New York: Oxford Univercity Press; 1998; pag.275; 2. Willett W, Stampfer MJ. Total energy intake, implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17‐27.)

- The approach of the authors in considering the results is cautious. In fact, even if they found that some of the adjusted measures of association between quintiles of the considered dietary exposures and health outcomes were significantly different from 1.0 when compared with the lowest quintile, they chose not to consider this evidence as a straightforward clue of true association. This choice is related to the fact that the estimated adjusted ORs for the association between the dietary exposures and the considered health outcomes are close to 1. This interpretation is quite reasonable. Nevertheless, in the discussion, the authors discuss some of their results, i.e. the slightly higher risk of eczema development in the offspring for women with a higher intake of vegetables and of certain nutrients. Why the author focused their attention only on eczema? Actually, the present study suggests also that women with a higher intake of total vegetables, folate rich vegetables, green and yellow vegetables, and certain nutrients have a slightly higher risk of food allergy and of other allergies. If they think it appropriate to discuss the results concerning eczema, they should discuss the results concerning food allergy and other allergies as well.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 28;16(1):e0245782. doi: 10.1371/journal.pone.0245782.r002

Author response to Decision Letter 0


10 Dec 2020

Reviewer #1

This novel paper investigates the potential association between maternal intake of vegetables during pregnancy and the risk of a range of childhood allergic diseases. The paper seek to add new knowledge to inconsistent results on this specific topic being conducting analyses in a large well conducted and well described young cohort. The authors apply appropriate statistical models and present a range of results, which are presented in a simple concise way. However, the authors could consider an alternative presentation of results in table 3. I have only a range of minor comments and some considerations, which could be added to the discussion.

Minor comments

Abstract:

Please add in relation to the aOR, 95% confidence intervals (95%CI) in the methods, and the results. And add the 95%CI to the presentation of results.

Thank you for pointing this out. We have added 95% confidence intervals in the methods and results sections as detailed below.

Lines 36-39

Using the categorizations as exposure variables, the adjusted odds ratios (aOR) with 95% confidence intervals (CI) were determined for the allergic outcomes, including asthma, wheeze, atopic dermatitis, eczema, and food allergy, in the offspring per quintile at one year of age.

Lines 43-46

The lowest aOR was found in the association of maternal cruciferous vegetable intake with asthma (aOR: 0.82, 95% CI: 0.70–0.96), and the highest was shown in the association of maternal total vegetable intake with atopic dermatitis (aOR: 1.17, 95% CI: 1.04–1.31).

Introduction:

Who has stated that “maternal vegetable intake during pregnancy is one of the most interesting exposures? Please, reconsider the use of “most interesting”

It would be relevant to add a few words on proposed mechanisms of the anti-oxidative and anti-inflammatory properties in relation to development of immune responses potentially working during fetal life – which later maybe related to development of allergic diseases.

Thank you very much for this suggestion. We have removed "most interesting" and added a few words on the proposed mechanisms as detailed below.

Lines 60-62

Maternal vegetable intake during pregnancy is an interesting exposure category due to the anti-oxidative and anti-inflammatory properties of vegetables, which may be related to the development of allergic diseases.

Please, add to the description of previous studies, the type of studies and range of n in the “relatively small sample sizes”.

Thank you for pointing this out. We have added the type of studies and the range of the sample as below.

Lines 68-70

One possible explanation for this inconsistency is the relatively small sample sizes (ranging from 310 to 3086) used in these observational studies.

Did any of the studies showing a positive association between vegetables and allergic diseases use register data or self-reported questionnaire data? Please, add a bit more information on these studies which can be used for discussion later.

Thank you very much for this comment. As all of the studies with a significant association were based on self-reported data, we have included this information in our revised manuscript, as detailed below.

Lines 62-64

Although several studies of maternal vegetable intake during pregnancy have investigated its association with the development of allergic disease in offspring using a self-reported database, they have yielded inconsistent results.

Materials and methods:

Line 89, In the method section, please add information in which gestational weeks the FFQ was completed.

Thank you for pointing this out. The FFQ was completed by the participant at any time during their pregnancy. We have added the gestational age when the FFQ was completed as follows.

Lines 86-88

A self-administered food frequency questionnaire (FFQ), which was completed during pregnancy (as a general rule, from 22+0 to 27+6), was used to assess the maternal diet during pregnancy.

Line 95-97: it is unclear whether women who were missing information in one variable only was excluded or not. Is it correct those women who were missing values on every outcome, were excluded – not if they were missing values in one or two, then they were kept in the analyses? Nevertheless, in line 97 the analyses used a complete dataset – meaning no missing values at all? Maybe change wording to ‘missing values on one or more outcomes’ if that were the case.

We apologize for the confusion. Our sample population included women with information about their vegetable intake on the FFQ and with at least one information on allergic outcomes. The missing number for each outcome is described in Table 1. We have revised this part as follows:

Lines 92-97

Women with a singleton delivery without congenital malformations were included. Women who were missing values on every outcome variable or failed to supply information about their vegetable intake on the FFQ were excluded (those missing one or two values were kept in our study population). Of those, our primary analysis was conducted based on the dataset with complete data on each variable, as our dataset contained a substantial sample.

Line 98: please add number of observations in the multiple imputation data set.

We apologize for this confusion. We have described our sample population in the statistical section as below.

Lines 148-156

Of the 90,422 women with a singleton delivery without a congenital malformation, 8,975 and 1,177 were excluded due to missing values for every outcome and no responses concerning vegetable intake on the FFQ, respectively. Thus, the remaining 80,270 women were included in our study population. Our main analysis was conducted after excluding those with missing data on confounding factors (n = 9,917) and each outcome (n for wheeze: 438, n for eczema: 387, n for any allergy: 311 [some of those overlapped with missing confounding factors]). Thus, the main analyses for asthma, wheeze, atopic dermatitis, eczema, food allergy, and any allergy were conducted for 70,353, 70,010, 70,353, 70,044, 70,353, and 70,103 people, respectively. A sensitivity analysis on 80,270 women using multiple imputations was conducted for the entire cohort (Fig 1).

Line 102: is it possible to add a reference to the “other nationally valid regulations”?

Thank you for this suggestion. We have added a reference in this sentence.

Lines 100-101

The JECS was conducted in accordance with the guidelines of the Declaration of Helsinki and other nationally valid regulations [19].

Line 106: please add mean gestational weeks of when the FFQ was completed during pregnancy.

Thank you very much for this important suggestion, and we agree with the importance of including the mean gestational weeks when the FFQ was completed. However, the gestational week dataset contains some missing or non-reliable data, and we were not able to accurately calculate the mean gestational age when the FFQ was completed. Thus, we can only state that the FFQ was completed by participants at some point during pregnancy, without the mean gestational age.

Lines 86-88

A self-administered food frequency questionnaire (FFQ), which was completed during pregnancy (as a general rule, from 22+0 to 27+6), was used to assess the maternal diet during pregnancy.

Line 107: what does the authors mean by ‘other profiles’? Please, add sufficient information in the text.

We apologize for this inaccurate sentence. We have revised as below.

Lines 106-107

The FFQ was completed during mid- to late-pregnancy, and other profiles of the FFQ have been described elsewhere in detail.

Regarding vegetables groups: Please, explain the rationale for having spinach in two groups. What are the pros and cons? Please, if any cons could influence the observed associations or interpretations of results, this should be included in the discussion.

Thank you for this comment. We agree that many nutritional studies have categorized food groups and nutritional groups by mutual exclusion. However, we aimed to determine how various kinds of vegetables are associated with allergic outcomes in offspring (based on a hypothesis that those categories may have different effects). The same categorization used in the current study has also been applied previously: PMID: 29434319). Folate-rich vegetables, green and yellow vegetables, and cruciferous vegetables are easy to understand categories, and both involve spinach. Considering our concept of this study, we believe that the current categorization is adequate. We have stated that our categorization was based on a previous study, as follows.

Lines 114-115

Vegetables were categorized into subclasses according to the following definitions, according to a previous study [9].

Line 125: Please, add one sentence on the validity of the ISSAC tool

Thank you very much for pointing this out. We have added a sentence on the validation as follows:

Lines 125-127

Wheezing and eczema symptoms in the offspring at this age were assessed using a questionnaire, which was modified from the International Study of Asthma and Allergies in Childhood (ISSAC) as a validated questionnaire.

Line 130: has the doctor’s diagnosis been validated at some point? How well is coverage of cases using the doctor diagnosis? Is there a risk of misclassification using these two tools for outcome assessments?

Thank you for pointing this out. This tool was not validated, and thus there could be a risk of misclassification. The coverage of cases was unknown. We have stated these as limitations of the current study, as below.

Lines 298-303

Third, although previous studies have used asthma, atopic dermatitis, and food allergy based on the doctor’s diagnosis as outcome variables [47, 48], these have not been validated. However, we complementally used those variables in addition to wheeze and eczema using a questionnaire because the assessment of allergic outcomes in offspring at one year of age is challenging. There may also have been some misclassification risk using two tools for the outcome assessment (self-reported questionnaire and doctor’s diagnosis).

Line 142: Please, add a sentence that the covariates were selected based on previous literature, which seems to be the case.

Thank you for this advice. We have revised as below.

Lines 144-145

The covariates were treated as confounding factors according to previous studies.

Line 146+148: there are some uncertainity about the numbers. The remaining 80,270 do have missing data, not on all outcomes but maybe some? Please, add n for the dataset used for the amin analysis with ‘women with no missing data’ and those ‘in the multiple imputation sensitivity analyses’

We apologize for this inaccurate description. The main analysis was based on women without missing confounding factors (n = 9,917) and each outcome. We have revised this part as below and added a Figure (flow chart).

Lines 148-157

Of the 90,422 women with a singleton delivery without a congenital malformation, 8,975 and 1,177 were excluded due to missing values for every outcome and no responses concerning vegetable intake on the FFQ, respectively. Thus, the remaining 80,270 women were included in our study population. Our main analysis was conducted after excluding those with missing data on confounding factors (n = 9,917) and each outcome (n for wheeze: 438, n for eczema: 387, n for any allergy: 311 [some of those overlapped with missing confounding factors]). Thus, the main analyses for asthma, wheeze, atopic dermatitis, eczema, food allergy, and any allergy were based on 70,353, 70,010, 70,353, 70,044, 70,353, and 70,103 people, respectively. A sensitivity analysis based on 80,270 women using multiple imputations was conducted for the entire cohort (Fig 1).

Fig 1: Flow chart showing the study population selection

The wording “ a quintile base on the energy-adjusted estimate of the intake for total vegetables” does not seem correct and is difficult to understand. Please reconsider this sentence and title for Figure 1.

We apologize for this incorrect sentence. However, as we noticed that this figure contained small information, thus we have decided to remove this figure and the relevant sentence.

An example of a quintile based on the energy-adjusted estimate of the total vegetable intake is shown in Fig 1.

Fig1: An example of a quintile based on the energy-adjusted intake for total vegetables

Table 1. In some lines, n(%) has been added to the test e.g. “Junior high school” but not by others e.g. “maternal allergic history” etc. Please, consider to be more consistent.

Maybe say “Allergic disorder at age 1” instead of “at endpoint”

Thank you for pointing this out. We have revised Table 1 accordingly.

Line 184: “for other kinds of vegetables” are to unspecific. Which vegetables are the authors referring to?

Thank you very much for pointing this out. We have revised this sentence to be more specific as below.

Lines 197-198

Similar aORs were observed for other vegetable subclass categories, including folate vegetables, green and yellow vegetables, and cruciferous vegetables.

Table 2 and 3. Please, try to make each column fit the text in a way that the results aOR (95%CI) can fit in one line. Makes it easier to read.

In the foot note, has ‘ART’ been written fully. I think, the authors should also write fully in a foot note.

Please, add that the unit is per day? Vitamin A ug/day. Also please, add n.

Thank you for this suggestion. We have revised Tables 2 and 3 to make them easier to read. We have changed ART to assisted reproductive technology in a foot note.

We have added that the unit is per day.

As Tables 2 and 3 are busy in their current form, we have created a separate supplemental table showing the number (S1 Table).

Line 207-208

Detailed data on the number of each quintile of vegetables and nutrients for the outcomes of interest are shown in S1 Table.

Would it be possible to makes figures or the like of (some) results in table 3? This tables is rather long across several pages.

Thank you for this suggestion. We have carefully considered how we could make them smaller (e.g., figures). However, we did not find a good solution. If we create a figure instead of Table 3, this may be inconsistent with Table 2. Thus, we propose that the current presentation in Table 3 may be better. We have tried to make it easier to read by making each column fit the text.

Even after taking these changes into consideration, Table 3 might be better presented as a supplemental table if the reviewer recommends this. However, as we believe the results shown in Table 3 are important, we hope to leave Table 3 in the main manuscript if possible.

The discussion:

The authors, briefly discuss the timing of the FFQ in relation to observed findings. However, is the timing relevant in relation to the development of auto immune responses in fetal life? And is the timing irrelevant since ‘most other studies did not focus on the time frame’?

Thank you very much for this comment. While the timing of the development of auto immune responses in fetal life is still unknown, several studies have shown that maternal exposure during specific pregnancy periods is associated with allergic outcomes in offspring. Thus, we have added a sentence explaining why we considered timing as a potential reason for these discrepancies.

Lines 227-230

One reason for this discrepancy might be the difference in the timeframes for assessing maternal dietary intake, as several studies have shown that maternal exposure during specific pregnancy periods is associated with allergic outcomes in offspring [9, 31-33].

The authors could discuss in more depth the ‘difficulties in assessing the asthma outcomes at age 1. Please see my questions above on the validity of outcome assessment, proc&cons

Thank you very much for this advice. We have discussed this in the limitation section, as follows.

Lines 298-303

Third, although previous studies have used asthma, atopic dermatitis, and food allergy based on the doctor’s diagnosis as outcome variables [47, 48], these have not been validated. However, we complementally used those variables in addition to wheeze and eczema using a questionnaire because the assessment of allergic outcomes in offspring at one-year-old is challenging. There may also have been some misclassification risk using two tools for the outcome assessment (self-reported questionnaire and doctor’s diagnosis).

Did any of the studies showing a positive association between vegetables and allergic diseases use register data or self-reported questionnaire data?

Thank you very much for this comment. As all of the studies with a significant association were based on self-reported data, we have added this information as below.

Lines 62-64

Although several studies of maternal vegetable intake during pregnancy have investigated its association with the development of allergic disease in offspring using a self-reported database, they have yielded inconsistent results.

How did the present study obtain the goal of being able to add significant knowledge to the existing knowledge base with this larger cohort study?

Thank you very much for this comment. We have added further detail on this as below.

Lines 284-290

The strength of our study includes the large sample size, which enabled the accurate assessment of the association between dietary intake and allergic outcomes as well as sufficient adjustment for potential confounders. We also confirmed the validity of the FFQ used in the current study because the mean EI/BMR in our samples was 1.52 (data not shown) [45]. Furthermore, although our sample included cases with missing information, a sensitivity analysis with an imputed dataset was used to confirm the accuracy of the data. We believe that the current study presents a reliable result on the association between maternal vegetable intake during pregnancy and allergic outcomes in offspring at one year of age.

Line 240: what is the prevalence of wheeze and asthma in older children?

We apologize for this confusion. Our intention with this sentence (as seen in wheeze and asthma development) is to highlight the non-significant association between maternal vegetable intake during pregnancy with wheeze and asthma in offspring at one year of age. Thus, we have revised this part as below.

Lines 251-255

Our results indicate the absence of a substantial risk for eczema development during the first year of life in offspring regardless of the category of maternal vegetable intake during pregnancy, suggesting that the association between maternal vegetable intake and eczema development depends on the age of the offspring, as seen in wheeze and asthma development in offspring at one year of age.

Line 277: does the authors mean? “using similar birth cohorts” or “using the same birth cohort with longer follow-up”?

Thank you very much for pointing this out. We have revised this as follows.

Lines 293-295

Further longitudinal studies investigating the association between maternal vegetable intake during pregnancy and the development of allergic disease in offspring using the same birth cohort over a longer follow-up period are warranted.

How would misclassification of dietary intake by the FFQ affect the observed associations? Please, add a sentence to the discussion.

Thank you very much for pointing this out. We have clarified the possible effect of this misclassification on the observed associations.

Lines 297-298

Furthermore, misclassification of dietary intake, which could lead to underestimation, may have occurred as the FFQ was self-reported.  

Reviewer #2

-

Dear authors,

This is a very interesting paper investigating the associations between maternal diet during pregnancy and allergic diseases in the offspring at age 1.

My main concern is the fact that the analysis were performed without adjusting on maternal breastfeeding, which can be a vety important factor in allergic diseases.

I would also suggest to adjust on maternal supplementation during pregnancy.

Thank you for this important suggestion. We added maternal breastfeeding and maternal folic acid supplementation during pregnancy (other supplementation is not popular for pregnant women in Japan) as confounders. Furthermore, we have added total energy intake as a confounder, according to other reviewers’ comments.

We have revised the method section as below.

Lines 140-144

Other variables, such as the place of recruitment, parental smoking status, maternal SES, including maternal education (junior high school, senior high school, university), household income (<4 million-yen, ≥4 and <6 million-yen, ≥6 million-yen), maternal folic acid supplementation during pregnancy (yes or no), and breastfeeding at one month after delivery (breastfeeding only, mixed feeding, artificial mild feeding), were obtained via a questionnaire at baseline.

Lines 165-171

For multivariate analysis, maternal age, place of recruitment, maternal height, pre-pregnancy body mass index (BMI), maternal weight gain during pregnancy, parity, conception method (assisted reproductive technology or not), pre-existing maternal hypertension, pre-existing maternal diabetes, parental allergic history, parental smoking, maternal education, maternal household income, infant gender, maternal folic acid supplementation during pregnancy, breastfeeding at one month after delivery, estimated maternal total energy intake during pregnancy, and delivery mode were adjusted.

My minor concern is : page 7, line 88 : please delete "the" before maternal.

Thank you for pointing this out. We deleted "the" as the reviewer commented.

Reviewer #3:

This paper aim at assessing the association between maternal intake of vegetables and related nutrients during pregnancy with allergic diseases in offspring at age 1 year. In order to reach this aim the authors use the information provided by a cohort study on a large sample of pregnant women. The information on dietary exposures was collected by means of a Food Frequency Questionnaire, whereas health outcomes in the offspring at age 1 year through the International Study of Asthma and Allergies in Childhood questionnaire.

The authors state that maternal intake of vegetables and other related nutrients during pregnancy had little or no association with the considered health outcomes in offspring at age 1 year.

The paper is well written and the authors have in general used proper methods to analyze their data. However, I would like to seek clarification on some points.

- Did the author perform some form of quality check on the FFQ questionnaire (for example: did they drop subjects with implausible values of estimated energy? Did they evaluate the ratio of energy intake to basal metabolic rate??

Thank you for this suggestion. We calculated the ratio of energy intake to the basal metabolic rate (EI/BMR) to evaluate the quality of the FFQ. As the mean EI/BMR in our samples was 1.52, we believe that the FFQ used in this study was adequate. We have stated this in the strength section as below.

Line 286-287

We also confirmed the validity of the FFQ used in the current study because the mean EI/BMR in our samples was 1.52 (data not shown) [45].

- Due to the poor quality of the image, I could not properly understand the utility of figure 1. What does figure 1 add to the text to explain how the authors created energy-adjusted quintiles of maternal vegetable intakes/related nutrients? Maybe some important details of the statistical model could be enlightened by this figure.

Thank you for this comment. As we noticed that this figure contained small information, we decided to remove this figure and the corresponding sentence.

An example of a quintile based on the energy-adjusted estimate of the total vegetable intake is shown in Fig 1.

Fig1: An example of a quintile based on the energy-adjusted intake for total vegetables

- The authors consider several covariates in the multivariate models. Among these covariates total energy intake is not present. Why? Even when the residual method is used, it is generally recommended to include total energy intake as a covariate in the model (see 1. Willet WC. Nutritional epidemiology 2nd ed. New York: Oxford Univercity Press; 1998; pag.275; 2. Willett W, Stampfer MJ. Total energy intake, implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17‐27.)

Thank you for this important suggestion. We have added the total energy intake as the reviewer pointed out. Furthermore, we have added maternal breastfeeding and maternal folic acid supplementation during pregnancy as confounders, according to the other reviewers' comments.

We have revised the method section as below.

Lines 165-171

For multivariate analysis, maternal age, place of recruitment, maternal height, pre-pregnancy body mass index (BMI), maternal weight gain during pregnancy, parity, conception method (assisted reproductive technology or not), pre-existing maternal hypertension, pre-existing maternal diabetes, parental allergic history, parental smoking, maternal education, maternal household income, infant gender, maternal folic acid supplementation during pregnancy, breastfeeding at one month after delivery, estimated maternal total energy intake during pregnancy, and delivery mode were adjusted.

- The approach of the authors in considering the results is cautious. In fact, even if they found that some of the adjusted measures of association between quintiles of the considered dietary exposures and health outcomes were significantly different from 1.0 when compared with the lowest quintile, they chose not to consider this evidence as a straightforward clue of true association. This choice is related to the fact that the estimated adjusted ORs for the association between the dietary exposures and the considered health outcomes are close to 1. This interpretation is quite reasonable. Nevertheless, in the discussion, the authors discuss some of their results, i.e. the slightly higher risk of eczema development in the offspring for women with a higher intake of vegetables and of certain nutrients. Why the author focused their attention only on eczema? Actually, the present study suggests also that women with a higher intake of total vegetables, folate rich vegetables, green and yellow vegetables, and certain nutrients have a slightly higher risk of food allergy and of other allergies. If they think it appropriate to discuss the results concerning eczema, they should discuss the results concerning food allergy and other allergies as well.

Thank you for pointing this out. We agree that we should discuss the results concerning food allergies. Because food allergy is a part of the allergy march, the hypothesis of this association is the same as eczema. Thus, we did not add another explanation for food allergy but revised it from the previous manuscript. Although women with a higher intake of vegetables also had a slightly higher risk of “any allergy,” this association may be due to eczema and food allergy. Thus, we did not discuss “any allergy” in this paragraph.

Lines 257-269

The present study also suggests that women with a higher intake of total vegetables, folate-rich vegetables, green and yellow vegetables, and certain nutrients have a slightly higher risk of their offspring developing eczema and food allergy. Although the reasons for this slightly elevated risk are difficult to ascertain, environmental factors, such as the presence of pesticide residues on produce grown in Japan, might provide an explanation. While no study has investigated the association between early-life exposure to pesticides and atopic dermatitis development in childhood, some studies have demonstrated a significant, positive association between pesticide exposure and the development of childhood asthma [35-37]. As childhood asthma, food allergy, and atopic dermatitis are part of the allergy march [38], atopic changes might be followed by food allergy and asthma as a consequence of prenatal exposure to unidentified environmental factors. Our results found no positive association between vegetable intake during pregnancy and asthma/wheeze or eczema in offspring; this may be due to the difficulty of assessing asthma outcomes at one year of age, as discussed above. Thus, future research on these topics is required.

Attachment

Submitted filename: Rebuttal_letter_PLOS_One_1206.docx

Decision Letter 1

Calistus Wilunda

8 Jan 2021

Association between maternal vegetable intake during pregnancy and allergy in offspring: Japan Environment and Children’s Study

PONE-D-20-22340R1

Dear Dr. kohei,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Calistus Wilunda, DrPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have sufficiently replied to my previous questions and i believe the paper is ready for publication. The supplementary table 1 works fine, I think. I have only a few minor comments for the authors to consider.

Minors

Lines 306-307: “ Furthermore, misclassification of dietary intake, which could lead to underestimation, may have occurred as the FFQ was self-reported.”

Does the authors mean “underestimation of the observed associations”? please, make the sentence a bit more clear/specific on what would be the consequence of misclassification of diet intake on the observed associations.

Line 236: One reason for this discrepancy might be the difference in the timeframes for assessing maternal dietary intake, as several studies have shown that maternal exposure during specific pregnancy periods is associated with allergic outcomes in offspring [9, 31-33].

The authors added an important consideration, however, it would give even more information if “the specific weeks of gestation” could be mentioned:

“One reason for this discrepancy might be the difference in the timeframes for assessing maternal dietary intake, as several studies have shown that maternal exposure during specific pregnancy periods (e.i. GW xx-xx) is associated with allergic outcomes in offspring [9, 31-33].”

The wording seems a bit incorrect: “S1 Table. Number of each quintile of vegetables and nutrients for the outcomes of interest” Should this be changed to: “S1 Table. Number of cases per quintile of vegetables and nutrients for each outcomes of interest” ? Should be revised in the manuscript accordingly.

This title of S3 should be revised to S4: “S4 Table. Relation between maternal vegetable intake and maternal allergic history”

In addition, does the table show relation or prevalence?

Reviewer #2: (No Response)

Reviewer #3: I think that the authors have adequately addressed my previous comments, in general. The changes made in response to the reviewers improved the manuscript. As a side comment, I would point out that when I asked some additional information on the evaluation of the quality of food frequency data, I expected the authors to make changes to the analysis dataset, for example by eliminating subjects with extreme values of EI, and/or of EI/BMR. In the modified version of the paper, the authors state that the average value of EI/BMR is 1.55, this does not exclude the existence of subjects with extreme and implausible values of that ratio. Even if I am not completely satisfied with this specific answer, nonetheless I believe that the methods used in the paper are in general valid and appropriate.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Acceptance letter

Calistus Wilunda

14 Jan 2021

PONE-D-20-22340R1

Association between maternal vegetable intake during pregnancy and allergy in offspring: Japan Environment and Children’s Study

Dear Dr. Ogawa:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Calistus Wilunda

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Number of each quintile of vegetables and nutrients for the outcomes of interest.

    (DOCX)

    S2 Table. Crude odds ratio of the allergic outcomes between quintiles for each exposure category.

    (DOCX)

    S3 Table. Association between maternal nutritional intake and allergic disease in offspring based on the imputed data set.

    (DOCX)

    S4 Table. Relationship between maternal vegetable intake and maternal allergic history.

    (DOCX)

    Attachment

    Submitted filename: Rebuttal_letter_PLOS_One_1206.docx

    Data Availability Statement

    Data are unsuitable for public deposition due to ethical restrictions and legal framework of Japan. It is prohibited by the Act on the Protection of Personal Information (Act No.57 of 30 May 2003, amendment on 9 September 2015) to publicly deposit the data containing personal information. Ethical Guidelines for Epidemiological Research enforced by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare also restricts the open sharing of the epidemiologic data. All inquiries about access to data should be sent to: jecs-en@nies.go.jp. The person responsible for handling enquiries sent to this e-mail address is Dr Shoji F. Nakayama, JECS Programme Office, National Institute for Environmental Studies.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES